載入...
Oxidative Stress and Proteasome Inhibitors in Multiple Myeloma
Multiple myeloma is a form of plasma cell neoplasm that accounts for approximately 10% of all hematological malignancies. Recently, several novel drugs have been discovered that almost doubled the overall survival of multiple myeloma patients. One of these drugs, the first-in-class proteasome inhibi...
Na minha lista:
| 發表在: | Pharmacol Res |
|---|---|
| Main Authors: | , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2016
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5044866/ https://ncbi.nlm.nih.gov/pubmed/26827824 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.phrs.2016.01.029 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|